Tags

Type your tag names separated by a space and hit enter

[Cancer epidemiology and trends in Switzerland].
Bull Cancer. 2007 Sep; 94(9):775-80.BC

Abstract

Trends in cancer mortality in Switzerland over the period 1980-2001 and of incidence in the Swiss Canton of Vaud (640,000 inhabitants) over the period 1974-2003 are reviewed and discussed. Steady declines in cancer mortality were observed, over the last decade, particularly from the mid-1980's, with falls in overall mortality of 11% in men and 8% in women. The fall was of 20 % in male lung, whereas lung cancer has steadily increased in women by 47 %. Substantial declines were observed for stomach and colorectum in both sexes, (cervix) uteri and breast in women. Declines were also observed for leukaemias, Hodgkin's disease and testicular cancer, namely the neoplasms most influenced by therapeutic improvements, while trends in lymphomas and myeloma showed no clear pattern. With reference to incidence in the Vaud population between 1979 and 2003, all major tobacco-related neoplasms have declined by 19% in men aged 35 to 64, but increased by 69% in all age women. In both sexes, age-adjusted incidence of all non-tobacco-related cancers has substantially increased, mostly in younger-middle age (+ 70% in men, + 33% in women). Trends are discussed in the perspective of the European Commission's target of a 15% reduction in total cancer mortality between 2000 and 2015.

Authors+Show Affiliations

Unité d'épidémiologie du cancer et Registre vaudois des tumeurs, Institut de médecine sociale et préventive (IUMSP), Centre hospitalier universitaire vaudois et Université de Lausanne, CHUV-Falaises 1, 1011 Lausanne, Suisse. Fabio.Levi@chuv.chNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

fre

PubMed ID

17878097

Citation

Levi, Fabio, and Carlo La Vecchia. "[Cancer Epidemiology and Trends in Switzerland]." Bulletin Du Cancer, vol. 94, no. 9, 2007, pp. 775-80.
Levi F, La Vecchia C. [Cancer epidemiology and trends in Switzerland]. Bull Cancer. 2007;94(9):775-80.
Levi, F., & La Vecchia, C. (2007). [Cancer epidemiology and trends in Switzerland]. Bulletin Du Cancer, 94(9), 775-80.
Levi F, La Vecchia C. [Cancer Epidemiology and Trends in Switzerland]. Bull Cancer. 2007;94(9):775-80. PubMed PMID: 17878097.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Cancer epidemiology and trends in Switzerland]. AU - Levi,Fabio, AU - La Vecchia,Carlo, PY - 2007/03/02/received PY - 2007/05/02/accepted PY - 2007/9/20/pubmed PY - 2007/10/13/medline PY - 2007/9/20/entrez SP - 775 EP - 80 JF - Bulletin du cancer JO - Bull Cancer VL - 94 IS - 9 N2 - Trends in cancer mortality in Switzerland over the period 1980-2001 and of incidence in the Swiss Canton of Vaud (640,000 inhabitants) over the period 1974-2003 are reviewed and discussed. Steady declines in cancer mortality were observed, over the last decade, particularly from the mid-1980's, with falls in overall mortality of 11% in men and 8% in women. The fall was of 20 % in male lung, whereas lung cancer has steadily increased in women by 47 %. Substantial declines were observed for stomach and colorectum in both sexes, (cervix) uteri and breast in women. Declines were also observed for leukaemias, Hodgkin's disease and testicular cancer, namely the neoplasms most influenced by therapeutic improvements, while trends in lymphomas and myeloma showed no clear pattern. With reference to incidence in the Vaud population between 1979 and 2003, all major tobacco-related neoplasms have declined by 19% in men aged 35 to 64, but increased by 69% in all age women. In both sexes, age-adjusted incidence of all non-tobacco-related cancers has substantially increased, mostly in younger-middle age (+ 70% in men, + 33% in women). Trends are discussed in the perspective of the European Commission's target of a 15% reduction in total cancer mortality between 2000 and 2015. SN - 1769-6917 UR - https://www.unboundmedicine.com/medline/citation/17878097/[Cancer_epidemiology_and_trends_in_Switzerland]_ L2 - http://www.jle.com/medline.md?issn=0007-4551&vol=94&iss=9&page=775 DB - PRIME DP - Unbound Medicine ER -